Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Parkinson disease

Deep brain stimulation versus best medical therapy for PD

A new study indicates that deep brain stimulation (DBS) plus best medical therapy markedly improves quality of life of patients with advanced Parkinson disease compared with best medical therapy alone. The frequency of serious adverse events related to DBS was similar to that reported in other DBS trials, underscoring the need for careful patient selection and counseling for this invasive therapy.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Williams, A. et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomized, open-label trial. Lancet Neurol. 9, 581–591 (2010).

    Article  Google Scholar 

  2. Weaver, F. et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease. JAMA 301, 63–73 (2009).

    Article  CAS  Google Scholar 

  3. Deuschl, G. et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N. Engl. J. Med. 355, 896–908 (2006).

    Article  CAS  Google Scholar 

  4. Moro, E. et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov. Disord. 25, 578–586 (2010).

    Article  Google Scholar 

  5. Gervais-Bernard, H. et al. Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: five year follow-up. J. Neurol. 256, 225–233 (2009).

    Article  Google Scholar 

  6. Schüpback, W. M. et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J. Neurol. Neurosurg. Psychiatry 76, 1640–1644 (2005).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matthew A. Brodsky.

Ethics declarations

Competing interests

M. A. Brodsky has received research funding from Medtronic. J. G. Nutt has received honoraria from Novartis for lectures and honoraria from Addex Pharmaceuticals, Elan Pharmaceuticals, Impax Laboratories, Medtronic, Merck, Neuroderm, Neurogen, Synosia Therapeutics, XenoPort for consulting. He has also received research funding from Merck.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brodsky, M., Nutt, J. Deep brain stimulation versus best medical therapy for PD. Nat Rev Neurol 6, 530–532 (2010). https://doi.org/10.1038/nrneurol.2010.128

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2010.128

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing